Results of a multicenter, phase-Ii clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy
Garin, A.M.; Gorbunova, V.A.; Bychkov, M.B.; Mindra, N.V.; Stenina, M.B.; Topchieva, S.V.; Treshchalina, E.M.; Chitiia, L.V.; Sdvizhkov, A.M.; Borisov, V.I.; Gurov, S.N.; Gershanovich, M.L.; Makhnova, E.V.; Nebol'sin, V.E.
Voprosy Onkologii 50(2): 184-188
2004
ISSN/ISBN: 0507-3758 PMID: 15176221 Document Number: 570124
Document emailed within 1 workday
Related Documents
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Jiang, Z.F.; Xu, F.R.; Fan, J.; Li, B.J.; Gao, J.N.; Hu, J.W.; Wang, X.J.; Zhang, Y.Q.; Wang, J.H.; Li, F.; Liu, Q.; Liu, Y.H.; Wang, S.; Wang, Y.S.; Ouyang, Q.C.; Hu, B.; Sun, G.P.; Zhang, Y.; Zang, A.M.; Fan, P.Z.; Wu, C.P.; Liu, J.; Zhang, H.W.; Wang, W.; Hu, X.C.; Tang, L.L.; Zhang, J.; Bao, Y.Y.; Geng, C.Z.; Sun, Q.; Zhang, F.; Yin, Y.M.; Jiang, H.C.; An, Y.H. 2018: A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer Zhonghua Yi Xue Za Zhi 98(16): 1231-1235
Katayose, Y.; Yamamoto, K.; Nakagawal, K.; Takemura, S.; Takahashi, M.; Nakamura, R.; Shimamura, H.; Rikiyama, T.; Egawa, S.; Yoshda, H.; Motoi, F.; Naitoh, T.; Unno, M. 2015: Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001) Hepato-Gastroenterology 62(138): 303-308
Cigolari, S.; Curcio, C.; Maiorino, A.; Sessa, R.; Cioffi, A.; Massimo, M. 2003: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Research 23(2c): 1803-1809
Rosenoff, S.H.; Gabrail, N.Y.; Conklin, R.; Hohneker, J.A.; Berg, W.J.; Warsi, G.; Maloney, J.; Benedetto, J.J.; Miles, E.A.; Zhu, W.; Anthony, L. 2006: A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial Journal of Supportive Oncology 4(6): 289-294
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205
Evans, W.K. 1988: Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trial Seminars in Oncology 15(6 Suppl. 7): 42-45
Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219
Natale, R.B. 1996: Preliminary results of a phase I/Ii clinical trial of paclitaxel and carboplatin in non-small cell lung cancer Seminars in Oncology 23(6 Suppl 16: 51-54
1995: Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone Zhonghua nei ke za zhi 34(9): 599-602
Gershanovich, M.L.; Garin, A.M.; Baltinia, D.; Kurvet, A.; Kangas, L.; Ellmen, I. 1997: Results of phase Ii clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women Voprosy Onkologii 43(6): 587-595
Debruyne, F.M.; Karthaus, H.F.; Schröder, F.H.; de Voogt, H.J.; de Jong, F.H.; Klijn, J.G. 1985: Results of a Dutch Phase Ii trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer Progress in Clinical and Biological Research 185a: 251-270
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Vici, P.; Giotta, F.; DI Lauro, L.; Brandi, M.; Gebbia, V.; Foggi, P.; Lorusso, V.; Vitucci, C.; Sergi, D.; Fattoruso, S.I.; Giannarelli, D.; Viola, G.; Corsetti, S.; Colucci, G.; Lopez, M. 2009: Multicenter phase Ii trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines Anticancer Research 29(5): 1841-1845
Metzger, U.; Laffer, U.; Aeberhard, P.; Arigoni, M.; Arma, S.; Barras, J.; Egeli, R.; Martinoli, S.; Mueller, W.; Schweizer, W. 1990: Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report Acta Chirurgica Scandinavica 156(6-7): 467-474
Fetting, J.H.; Siminoff, L.A.; Piantadosi, S.; Abeloff, M.D.; Damron, D.J.; Sarsfield, A.M. 1990: Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(9): 1476-1482
Gravis, G.; Mousseau, M.; Douillard, J.Y.; Dorval, T.; Fabbro, M.; Escudier, B.; Mignot, L.; Viens, P. 2001: Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial European Cytokine Network 12(2): 239-243
Kris, M.G.; Kinahan, J.J.; Gralla, R.J.; Fanucchi, M.P.; Wertheim, M.S.; O'Connell, J.P.; Marks, L.D.; Williams, L.; Farag, F.; Young, C.W. 1988: Phase i trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer Cancer Research 48(19): 5573-5579
Zhu, X.; Zheng, M.; Song, M.; Shen, Y.-K.; Chan, D.; Szapary, P.O.; Wang, B.; Wang, B.; Tu, C.; Hao, F.; Jin, H.; Xu, J.; Gu, J.; Zheng, M.; Gao, T.; Lai, W.; Liu, X.; Gao, X.; Zhu, X.; Zhang, J.; Zheng, J. 2013: Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS) Journal of Drugs in Dermatology: Jdd 12(2): 166-174